Invesco Ltd. - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$92,152
-10.4%
53,577
+1.6%
0.00%
Q2 2023$102,813
+80.4%
52,725
+279.7%
0.00%
Q1 2022$57,000
-99.4%
13,885
-98.1%
0.00%
-100.0%
Q4 2021$9,576,000
+114.7%
744,600
+80.3%
0.00%
+100.0%
Q3 2021$4,460,000
+139.0%
412,938
+102.0%
0.00%
Q2 2021$1,866,000204,4220.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$17,536,0001.82%
EcoR1 Capital, LLC 3,421,287$13,480,0000.72%
FRAZIER MANAGEMENT LLC 2,061,758$8,123,0000.63%
BVF INC/IL 2,695,418$10,620,0000.42%
Column Group LLC 869,493$3,426,0000.31%
Avidity Partners Management LP 2,122,064$8,361,0000.27%
Redmile Group, LLC 3,059,794$12,056,0000.15%
SkyOak Wealth, LLC 69,778$275,0000.09%
Tekla Capital Management LLC 419,005$1,651,0000.06%
Blackstone Inc. 2,567,445$10,116,0000.04%
View complete list of GRITSTONE ONCOLOGY INC shareholders